Mubadala to acquire Kelix bio in push to expand life sciences portfolio

Mubadala Investment Company, Abu Dhabi’s strategic investment arm, is to acquire emerging markets-focused speciality pharmaceutical company Kelix bio in a push to further develop the UAE’s life sciences ecosystem.Mubadala entered…
Read More

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button